Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes

Van Trung Chu, Timm Weber, Robin Graf, +6

BMC Biotechnology

Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer

Ulrike Sack, Wolfgang Walther, Dominic A. Scudiero, +7

JNCI Journal of the National Cancer Institute

S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells

Ulrike Sack, Wolfgang Walther, Dominic A. Scudiero, +7

Molecular Biology of the Cell

Therefore CalcimycinCancer BiologyTumor BiologyTranscriptional RegulationSignaling Pathway +15

Intervening in β-Catenin Signaling by Sulindac Inhibits S100A4-Dependent Colon Cancer Metastasis

Ulrike Stein, Franziska Arlt, Janice Smith, +7

Neoplasia

In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice

Andreas Pichorner, Ulrike Sack, Dennis Kobelt, +6

Clinical & Experimental Metastasis

Vivo ImagingColorectal Cancer GrowthOncologyXenografted MiceMedicine +8

Wnt up your mind - intervention strategies for S100A4-induced metastasis in colon cancer.

Ulrike Sack, Ulrike Stein

PubMed

PathologyCancer BiologyTumor BiologyOncologySignaling Pathway +17

Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis

Thomas Sommermann, Tomoharu Yasuda, Jonathan Ronen, +12

Proceedings of the National Academy of Sciences

Lymphoid NeoplasiaEpstein-barr VirusLymphocyte DevelopmentImmunologyB Cell Lymphomagenesis +12

Systemic shRNA mediated knock-down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation

Mathias Dahlmann, Ulrike Sack, Pia Herrmann, +4

Oncotarget

Multiple isoforms of the translation initiation factor eIF4GII are generated via use of alternative promoters, splice sites and a non-canonical initiation codon

Mark J. Coldwell, Ulrike Sack, Joanne L. Cowan, +4

Biochemical Journal

Anti-metastatic Treatment in Colorectal Cancer: Targeting Signaling Pathways

Clara Lemos, Ulrike Sack, Felicitas Schmid, +2

Current Pharmaceutical Design

Tumor BiologyMedicineImmunologyColorectal CancerPathology +8